Diffusion tensor imaging and related techniques in tuberous sclerosis complex: Review and future directions

Future Neurology

Volumn 8, Issue 5, 2013, Pages 583-597

  Peters, Jurriaan M ^a   Taquet, Maxime ^a,b   Prohl, Anna K ^a   Scherrer, Benoit ^a   Van Eeghen, Agnies M ^b   Prabhu, Sanjay P ^a   Sahin, Mustafa ^a   Warfield, Simon K ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

autism spectrum disorders; behavior; cognition; diffusion tensor imaging; epilepsy; MRI; mTOR serine threonine kinases; tuberous sclerosis complex

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR;

AUTISM; BRAIN DISEASE; CORTICAL TUBER; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; EPILEPSY; GLIOSIS; HUMAN; IMAGE DISPLAY; IMAGE RECONSTRUCTION; INTELLECTUAL IMPAIRMENT; MICROMORPHOLOGY; NEUROIMAGING; NEUROPATHOLOGY; NEUROSURGERY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SUBEPENDYMAL GIANT CELL ASTROCYTOMA; SUBEPENDYMAL NODULE; TUBEROUS SCLEROSIS; VOXEL BASED MORPHOMETRY; WHITE MATTER;

EID: 84883405212     PISSN: 14796708     EISSN: 17486971     Source Type: Journal    
DOI: 10.2217/fnl.13.37     Document Type: Review

References (123)

1. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N. Engl. J. Med. 355(13), 1345-1356 (2006).
2. Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann. NY Acad. Sci. 615, 125-127 (1991).
3. Ess KC. The neurobiology of tuberous sclerosis complex. Semin. Pediatr. Neurol. 13(1), 37-42 (2006).
4. Jentarra G, Snyder SL, Narayanan V. Genetic aspects of neurocutaneous disorders. Semin. Pediatr. Neurol. 13(1), 43-47 (2006).
5. Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet 372(9639), 657-668 (2008).
6. Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: Revised clinical diagnostic criteria. J. Child Neurol. 13(12), 624-628 (1998).
7. Datta AN, Hahn CD, Sahin M. Clinical presentation and diagnosis of tuberous sclerosis complex in infancy. J. Child Neurol. 23(3), 268-273 (2008).
8. Dabora SL, Jozwiak S, Franz DN et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am. J. Hum. Genet. 68(1), 64-80 (2001).
9. Jeste SS, Sahin M, Bolton P, Ploubidis GB, Humphrey A. Characterization of autism in young children with tuberous sclerosis complex. J. Child Neurol. 23(5), 520-525 (2008).
10. Bolton PF, Park RJ, Higgins JN, Griffiths PD, Pickles A. Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain 125(Pt 6), 1247-1255 (2002).
11. Eluvathingal TJ, Behen ME, Chugani HT et al. Cerebellar lesions in tuberous sclerosis complex: neurobehavioral and neuroimaging correlates. J. Child Neurol. 21(10), 846-851 (2006).
12. Walz NC, Byars AW, Egelhoff JC, Franz DN. Supratentorial tuber location and autism in tuberous sclerosis complex. J. Child Neurol. 17(11), 830-832 (2002).
13. Weber AM, Egelhoff JC, McKellop JM, Franz DN. Autism and the cerebellum: Evidence from tuberous sclerosis. J. Autism Dev. Disord. 30(6), 511-517 (2000).
14. Wong V. Study of the relationship between tuberous sclerosis complex and autistic disorder. J. Child Neurol. 21(3), 199-204 (2006).
15. Goodman M, Lamm SH, Engel A, Shepherd CW, Houser OW, Gomez MR. Cortical tuber count: A biomarker indicating neurologic severity of tuberous sclerosis complex. J. Child Neurol. 12(2), 85-90 (1997).
16. Jansen FE, Vincken KL, Algra A et al. Cognitive impairment in tuberous sclerosis complex is a multifactorial condition. Neurology 70(12), 916-923 (2008). tudies the relationship between clinical (epilepsy), imaging and neuropsychological variables.
17. Wong V, Khong PL. Tuberous sclerosis complex: Correlation of magnetic resonance imaging (MRI) findings with comorbidities. J. Child Neurol. 21(2), 99-105 (2006).
18. Asano E, Chugani DC, Muzik O et al. Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex. Neurology 54(10), 1976-1984 (2000).
19. Jansen FE, Braun KP, van Nieuwenhuizen O et al. Diffusion-weighted magnetic resonance imaging and identification of the epileptogenic tuber in patients with tuberous sclerosis. Arch. Neurol. 60(11), 1580-1584 (2003).
20. Choi YJ, Di Nardo A, Kramvis I et al. Tuberous sclerosis complex proteins control axon formation. Genes Dev. 22(18), 2485-2495 (2008).
21. Meikle L, Talos DM, Onda H et al. A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J. Neurosci. 27(21), 5546-5558 (2007).
22. Nie D, Di Nardo A, Han JM et al. Tsc2-Rheb signaling regulates EphA-mediated axon guidance. Nat. Neurosci. 13(2), 163-172 (2010).
23. Peters JM, Sahin M, Vogel-Farley VK et al. Loss of white matter microstructural integrity is associated with adverse neurological outcome in tuberous sclerosis complex. Acad. Radiol. 19(1), 17-25 (2012). First report of sufficient power to suggest a relationship between diffusion tensor imaging of the white matter and neurocognitive phenotype in tuberous sclerosis complex.
24. Lewis WW, Sahin M, Scherrer B et al. Impaired language pathways in tuberous sclerosis complex patients with autism spectrum disorders. Cereb. Cortex 23(7), 1526-1532 (2013).
25. Krishnan ML, Commowick O, Jeste SS et al. Diffusion features of white matter in tuberous sclerosis with tractography. Pediatr. Neurol. 42(2), 101-106 (2010).
26. Goldberg-Zimring D, Mewes AU, Maddah M, Warfield SK. Diffusion tensor magnetic resonance imaging in multiple sclerosis. J. Neuroimaging 15(SUPPL. 4), S68-S81 (2005).
27. Bozzali M, Falini A, Franceschi M et al. White matter damage in Alzheimers disease assessed in vivo using diffusion tensor magnetic resonance imaging. J. Neurol. Neurosurg. Psychiatry 72(6), 742-746 (2002).
28. Luat AF, Chugani HT. Molecular and diffusion tensor imaging of epileptic networks. Epilepsia 49(SUPPL. 3), 15-22 (2008).
29. Curatolo P, Verdecchia M, Bombardieri R. Tuberous sclerosis complex: A review of neurological aspects. Eur. J. Paediatr.Neurol. 6(1), 15-23 (2002).
30. Crino PB, Henske EP. New developments in the neurobiology of the tuberous sclerosis complex. Neurology 53(7), 1384-1390 (1999).
31. Kato T, Yamanouchi H, Sugai K, Takashima S. Improved detection of cortical and subcortical tubers in tuberous sclerosis by fluid-attenuated inversion recovery MRI. Neuroradiology 39(5), 378-380 (1997).
32. Takanashi J, Sugita K, Fujii K, Niimi H. MR evaluation of tuberous sclerosis: Increased sensitivity with fluid-attenuated inversion recovery and relation to severity of seizures and mental retardation. AJNR Am. J. Neuroradiol. 16(9), 1923-1928 (1995).
33. Gallagher A, Grant EP, Madan N, Jarrett DY, Lyczkowski DA, Thiele EA. MRI findings reveal three different types of tubers in patients with tuberous sclerosis complex. J. Neurol. 257(8), 1373-1381 (2010).
34. Tsai P, Sahin M. Mechanisms of neurocognitive dysfunction and therapeutic considerations in tuberous sclerosis complex. Curr. Opin. Neurol. 24(2), 106-113 (2011).
35. Vaughn J, Hagiwara M, Katz J et al. MRI characterization and longitudinal study of focal cerebellar lesions in a young tuberous sclerosis cohort. AJNR Am. J. Neuroradiol. 34(3), 655-659 (2013).
36. Kalantari BN, Salamon N. Neuroimaging of tuberous sclerosis: Spectrum of pathologic findings and frontiers in imaging. AJR Am. J. Roentgenol. 190(5), W304-309 (2008).
37. Nabbout R, Santos M, Rolland Y, Delalande O, Dulac O, Chiron C. Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis. J. Neurol. Neurosurg. Psychiatry 66(3), 370-375 (1999).
38. Griffiths PD, Bolton P, Verity C. White matter abnormalities in tuberous sclerosis complex. Acta Radiol. 39(5), 482-486 (1998).
39. Chu-Shore CJ, Major P, Montenegro M, Thiele E. Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex. Neurology 72(13), 1165-1169 (2009).
40. Rott HD, Lemcke B, Zenker M, Huk W, Horst J, Mayer K. Cyst-like cerebral lesions in tuberous sclerosis. Am. J. Med. Genet. 111(4), 435-439 (2002).
41. Chu-Shore CJ, Frosch MP, Grant PE, Thiele EA. Progressive multifocal cystlike cortical tubers in tuberous sclerosis complex: Clinical and neuropathologic findings. Epilepsia 50(12), 2648-2651 (2009).
42. Galluzzi P, Cerase A, Strambi M, Buoni S, Fois A, Venturi C. Hemimegalencephaly in tuberous sclerosis complex. J. Child Neurol. 17(9), 677-680 (2002).
43. Griffiths PD, Gardner SA, Smith M, Rittey C, Powell T. Hemimegalencephaly and focal megalencephaly in tuberous sclerosis complex. AJNR Am. J. Neuroradiol. 19(10), 1935-1938 (1998).
44. Huntsman RJ, Sinclair DB, Richer LP. Tuberous sclerosis with open lipped schizencephaly. Pediatr. Neurol. 34(3), 231-234 (2006).
45. Weisenfeld NI, Peters JM, Tsai PT et al. A magnetic resonance imaging study of cerebellar volume in tuberous sclerosis complex. Pediatr. Neurol. 48(2), 105-110 (2013).
46. Bitar R, Leung G, Perng R et al. MR pulse sequences: What every radiologist wants to know but is afraid to ask. Radiographics 26(2), 513-537 (2006). Entry-level review regarding the physics of MRI and different acquisition schemes.
47. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: Application to diffusion and perfusion in neurologic disorders. Radiology 161(2), 401-407 (1986).
48. Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di Chiro G. Diffusion tensor MR imaging of the human brain. Radiology 201(3), 637-648 (1996).
49. Piao C, Yu A, Li K, Wang Y, Qin W, Xue S. Cerebral diffusion tensor imaging in tuberous sclerosis. Eur. J. Radiol. 71(2), 249-252 (2009).
50. Basser PJ, Pajevic S, Pierpaoli C, Duda J, Aldroubi A. In vivo fiber tractography using DT-MRI data. Magn. Reson. Med. 44(4), 625-632 (2000).
51. Mori S, Kaufmann WE, Pearlson GD et al. In vivo visualization of human neural pathways by magnetic resonance imaging. Ann. Neurol. 47(3), 412-414 (2000).
52. Wakana S, Jiang H, Nagae-Poetscher LM, van Zijl PC, Mori S. Fiber tract-based atlas of human white matter anatomy. Radiology 230(1), 77-87 (2004).
53. Jiang Y, Johnson GA. Microscopic diffusion tensor imaging of the mouse brain. Neuroimage 50(2), 465-471 (2009).
54. Budde MD, Xie M, Cross AH, Song SK. Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: A quantitative pixelwise analysis. J. Neurosci. 29(9), 2805-2813 (2009).
55. Song SK, Yoshino J, Le TQ et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 26(1), 132-140 (2005).
56. Sun SW, Liang HF, Trinkaus K, Cross AH, Armstrong RC, Song SK. Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum. Magn. Reson. Med. 55(2), 302-308 (2006).
57. Beaulieu C, Allen PS. Determinants of anisotropic water diffusion in nerves. Magn. Reson. Med. 31(4), 394-400 (1994).
58. Gulani V, Webb AG, Duncan ID, Lauterbur PC. Apparent diffusion tensor measurements in myelin-deficient rat spinal cords. Magn. Reson. Med. 45(2), 191-195 (2001).
59. Bandettini PA. Whats new in neuroimaging methods Ann. NY Acad. Sci. 1156, 260-293 (2009).
60. Mori S, van Zijl PC. Fiber tracking: Principles and strategies - a technical review. NMR Biomed. 15(7-8), 468-480 (2002).
61. Tournier JD, Mori S, Leemans A. Diffusion tensor imaging and beyond. Magn. Reson. Med. 65(6), 1532-1556 (2011).
62. Jeurissen B, Leemans A, Tournier JD, Jones DK, Sijbers J. Investigating the prevalence of complex fiber configurations in white matter tissue with diffusion magnetic resonance imaging. Hum. Brain Mapp. doi:10.1002/hbm.22099 (2012) (Epub ahead of print).
63. Vos SB, Jones DK, Jeurissen B, Viergever MA, Leemans A. The influence of complex white matter architecture on the mean diffusivity in diffusion tensor MRI of the human brain. Neuroimage 59 3), 2208-2216 (2011).
64. Sener RN. Tuberous sclerosis: Diffusion MRI findings in the brain. Eur. Radiol. 12(1), 138-143 (2002).
65. Widjaja E, Simao G, Mahmoodabadi SZ et al. Diffusion tensor imaging identifies changes in normal-appearing white matter within the epileptogenic zone in tuberous sclerosis complex. Epilepsy Res. 89(2-3), 246-253 (2010).
66. Garaci FG, Floris R, BozzaoA et al. Increased brain apparent diffusion coefficient in tuberous sclerosis. Radiology 232(2), 461-465 (2004).
67. Makki MI, Chugani DC, Janisse J, Chugani HT. Characteristics of abnormal diffusivity in normal-appearing white matter investigated with diffusion tensor MR imaging in tuberous sclerosis complex. AJNR Am. J. Neuroradiol. 28(9), 1662-1667 (2007).
68. Simao G, Raybaud C, Chuang S, Go C, Snead OC, Widjaja E. Diffusion tensor imaging of commissural and projection white matter in tuberous sclerosis complex and correlation with tuber load. AJNR Am. J. Neuroradiol. 31(7), 1273-1277 (2010).
69. van Eeghen AM, Terán LO, Johnson J, Pulsifer MB, Thiele EA, Caruso P. The neuroanatomical phenotype of tuberous sclerosis complex: focus on radial migration lines. Neuroradiology 55(8), 1007-1014 (2013).
70. Clarke MJ, Foy AB, Wetjen N, Raffel C. Imaging characteristics and growth of subependymal giant cell astrocytomas. Neurosurg. Focus 20(1), E5 (2006).
71. Moavero R, Pinci M, Bombardieri R, Curatolo P. The management of subependymal giant cell tumors in tuberous sclerosis: A clinicians perspective. Childs Nerv. Syst. 27(8), 1203-1210 (2011).
72. Berhouma M. Management of subependymal giant cell tumors in tuberous sclerosis complex: The neurosurgeons perspective. World J. Pediatr. 6(2), 103-110.
73. Krueger DA, Care MM, Holland K et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N. Engl. J. Med. 363(19), 1801-1811 (2010).
74. Peng SS, Lee WT, Wang YH, Huang KM. Cerebral diffusion tensor images in children with tuberous sclerosis: A preliminary report. Pediatr. Radiol. 34(5), 387-392 (2004).
75. Arulrajah S, Ertan G, Jordan L et al. Magnetic resonance imaging and diffusion-weighted imaging of normal-appearing white matter in children and young adults with tuberous sclerosis complex. Neuroradiology 51(11), 781-786 (2009).
76. Karadag D, Mentzel HJ, Gullmar D et al. Diffusion tensor imaging in children and adolescents with tuberous sclerosis. Pediatr. Radiol. 35(10), 980-983 (2005).
77. Firat AK, Karakas HM, Erdem G, Yakinci C, Bicak U. Diffusion weighted MR findings of brain involvement in tuberous sclerosis. Diagn. Interv. Radiol. 12(2), 57-60 (2006).
78. Marcotte L, Aronica E, Baybis M, Crino PB. Cytoarchitectural alterations are widespread in cerebral cortex in tuberous sclerosis complex. Acta Neuropathol. 123(5), 685-693 (2012). Demonstrates widespread microstructural pathology in tuberous sclerosis complex.
79. Tillema JM, Leach JL, Krueger DA, Franz DN. Everolimus alters white matter diffusion in tuberous sclerosis complex. Neurology 78(8), 526-531 (2012). Suggests that diffusion tensor imaging parameters of white matter may improve with the use of mTOR inhibitors, indicating microstructural alterations.
80. Numis AL, Major P, Montenegro MA, Muzykewicz DA, Pulsifer MB, Thiele EA. Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex. Neurology 76(11), 981-987 (2011).
81. Muzykewicz DA, Costello DJ, Halpern EF, Thiele EA. Infantile spasms in tuberous sclerosis complex: Prognostic utility of EEG. Epilepsia 50(2), 290-296 (2009).
82. Jozwiak S, Kotulska K, Domanska-Pakiela D et al. Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex. Eur J. Paediatr.Neurol. 15(5), 424-431 (2011). Suggests that treatment of patients with tuberous sclerosis complex and certain EEG patterns before onset of infantile spasms improves neurological outcome.
83. Bombardieri R, Pinci M, Moavero R, Cerminara C, Curatolo P. Early control of seizures improves long-term outcome in children with tuberous sclerosis complex. Eur. J. Paediatr. Neurol. 14(2), 146-149 (2010).
84. Otte WM, van Eijsden P, Sander JW, Duncan JS, Dijkhuizen RM, Braun KP. A meta-analysis of white matter changes in temporal lobe epilepsy as studied with diffusion tensor imaging. Epilepsia 53(4), 659-667 (2012).
85. Chandra PS, Salamon N, Huang J et al. FDG-PET/MRI coregistration and diffusion-tensor imaging distinguish epileptogenic tubers and cortex in patients with tuberous sclerosis complex: A preliminary report. Epilepsia 47(9), 1543-1549 (2006).
86. Gallagher A, Chu-Shore CJ, Montenegro MA et al. Associations between electroencephalographic and magnetic resonance imaging findings in tuberous sclerosis complex. Epilepsy Res. 87(2-3), 197-202 (2009).
87. Koh S, Jayakar P, Dunoyer C et al. Epilepsy surgery in children with tuberous sclerosis complex: Presurgical evaluation and outcome. Epilepsia 41(9), 1206-1213 (2000).
88. Mohamed AR, Bailey CA, Freeman JL, Maixner W, Jackson GD, Harvey AS. Intrinsic epileptogenicity of cortical tubers revealed by intracranial EEG monitoring. Neurology 79(23), 2249-2257 (2012).
89. Major P, Rakowski S, Simon MV et al. Are cortical tubers epileptogenic Evidence from electrocorticography. Epilepsia 50(1), 147-154 (2009).
90. Ma TS, Elliott RE, Ruppe V et al. Electrocorticographic evidence of perituberal cortex epileptogenicity in tuberous sclerosis complex. J. Neurosurg. Pediatr. 10(5), 376-382 (2012).
91. Jansen FE, van Huffelen AC, Algra A, van Nieuwenhuizen O. Epilepsy surgery in tuberous sclerosis: A systematic review. Epilepsia 48(8), 1477-1484 (2007).
92. Mori K, Mori T, Toda Y et al. Decreased benzodiazepine receptor and increased GABA level in cortical tubers in tuberous sclerosis complex. Brain Dev. 34(6), 478-486 (2012).
93. Jansen FE, van Huffelen AC, Bourez-Swart M, van Nieuwenhuizen O. Consistent localization of interictal epileptiform activity on EEGs of patients with tuberous sclerosis complex. Epilepsia 46(3), 415-419 (2005).
94. Jambaque I, Cusmai R, Curatolo P, Cortesi F, Perrot C, Dulac O. Neuropsychological aspects of tuberous sclerosis in relation to epilepsy and MRI findings. Dev. Med. Child Neurol. 33(8), 698-705 (1991).
95. Ridler K, Suckling J, Higgins N, Bolton P, Bullmore E. Standardized whole brain mapping of tubers and subependymal nodules in tuberous sclerosis complex. J. Child Neurol. 19(9), 658-665 (2004).
96. Ertan G, Arulrajah S, Tekes A, Jordan L, Huisman TA. Cerebellar abnormality in children and young adults with tuberous sclerosis complex: MR and diffusion weighted imaging findings. J. Neuroradiol. 37(4), 231-238 (2010).
97. Asano E, Chugani DC, Muzik O et al. Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction. Neurology 57(7), 1269-1277 (2001).
98. Tsai PT, Hull C, Chu Y et al. Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature 488(7413), 647-651 (2012). Mouse model with cerebellar injury from Tsc1 mutations displays autistic behaviors.
99. van Eeghen AM, Pulsifer MB, Merker VL et al. Understanding relationships between autism, intelligence, and epilepsy: A cross-disorder approach. Dev. Med. Child Neurol. 55(2), 146-153 (2013).
100. Keller TA, Kana RK, Just MA. A developmental study of the structural integrity of white matter in autism. Neuroreport 18(1), 23-27 (2007).
101. Alexander AL, Lee JE, Lazar M et al. Diffusion tensor imaging of the corpus callosum in autism. Neuroimage 34(1), 61-73 (2007).
102. Fletcher PT, Whitaker RT, Tao R et al. Microstructural connectivity of the arcuate fasciculus in adolescents with high-functioning autism. Neuroimage 51(3), 1117-1125 (2010).
103. Travers BG, Adluru N, Ennis C et al. Diffusion tensor imaging in autism spectrum disorder: A review. Autism Res. 5(5), 289-313 (2012).
104. Geschwind DH, Levitt P. Autism spectrum disorders: Developmental disconnection syndromes. Curr. Opin. Neurobiol. 17(1), 103-111 (2007).
105. Peters JM, Taquet M, Vega C et al. Brain functional networks in syndromic and non-syndromic autism: A graph theoretical study of EEG connectivity. BMC Med. 11(1), 54 (2013). EEG study that found similar abnormalities in functional connectivity in nonsyndromic (idiopathic) and syndromic (tuberous sclerosis complex) autism, suggesting common biological mechanisms.
106. Tuch DS, Reese TG, Wiegell MR, Makris N, Belliveau JW, Wedeen VJ. High angular resolution diffusion imaging reveals intravoxel white matter fiber heterogeneity. Magn. Reson. Med. 48(4), 577-582 (2002).
107. Taquet M, Scherrer B, Commowick O et al. Registration and analysis of white matter group differences with a multi-fiber model. Med. Image Comput. Comput. Assist. Interv. 15(Pt 3), 313-320 (2012).
108. Scherrer B, Warfield SK. Parametric representation of multiple white matter fascicles from cube and sphere diffusion MRI. PLoS ONE 7(11), e48232 (2012).
109. Taquet M, Scherrer B, Boumal M, Macq B, Warfield SK. Estimation of a multi-fascicle model from single b-value data with a population-informed prior. Med. Image Comput. Comput. Assist. Interv. (2013) (In Press). First study to demonstrate that estimation of multiple fascicles is possible with routine, short acquisition schemes and a single b-value.
110. Scherrer B, Taquet M, Warfield SK. Reliable selection of the number of fascicles in diffusion images by estimation of the generalization error. Inf. Process. Med. Imaging 7917, 742-753 (2013).
111. Pasternak O, Westin CF, Bouix S et al. Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset. J. Neurosci. 32(48), 17365-17372 (2012).
112. Wang Y, Wang Q, Haldar JP et al. Quantification of increased cellularity during inflammatory demyelination. Brain 134(Pt 12), 3590-3601 (2011).
113. Kwiatkowski DJ, Manning BD. Tuberous sclerosis: A GAP at the crossroads of multiple signaling pathways. Hum. Mol. Genet. 14(Spec. No 2), R251-R258 (2005).
114. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 124(3), 471-484 (2006).
115. Sahin M. Targeted treatment trials for tuberous sclerosis and autism: no longer a dream. Curr. Opin. Neurobiol. 22, 1-7 (2012).
116. Franz DN, Belousova E, Sparagana S et al. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): A multicentre, randomised, placebo-controlled Phase 3 trial. Lancet 381(9861), 125-132 (2012).
117. Kotulska K, Chmielewski D, Borkowska J et al. Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex. Eur. J. Paediatr. Neurol. doi:10.1016/j. ejpn.2013.03.002 (2013) (Epub ahead of print).
118. Meikle L, Pollizzi K, EgnorA et al. Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: Effects on mTORC1 and Akt signaling lead to improved survival and function. J. Neurosci. 28(21), 5422-5432 (2008).
119. Zeng LH, Xu L, Gutmann DH, Wong M. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann. Neurol. 63(4), 444-453 (2008).
120. Wong M. Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies. Epilepsia 51(1), 27-36 (2010).
121. Ehninger D, Han S, Shilyansky C et al. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat. Med. 14(8), 843-848 (2008).
122. Wakana S, Caprihan A, Panzenboeck MM et al. Reproducibility of quantitative tractography methods applied to cerebral white matter. Neuroimage 36(3), 630-644 (2007). Website
123. Roberds S. Diagnostic criteria.Tuberous Sclerosis Alliance. How is TSC diagnosed (2013). www.tsalliance.org/pages.aspxcontent=10 (Accessed 1 July 2013)